Start SIP inStart SIP
Sun Pharma Advd.Resh. has an operating revenue of Rs. 147.39 Cr. on a trailing 12-month basis. An annual revenue de-growth of -44% needs improvement, Pre-tax margin of -148% needs improvement, ROE of -651% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 5% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 152 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
NSE-Medical-Biomed/BiotechSun Pharma Advanced is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 137.25 Cr. and Equity Capital is Rs. 27.19 Cr. for the Year ended 31/03/2022. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.
|Shares in Float||8.43|
|No of funds||68|
|U/D Vol ratio||1.8|
|LTDebt / Equity|
|Foreign Portfolio Investors||2.38%||2.4%||2.38%|
|Financial Institutions/ Banks|
|Mr. Dilip S Shanghvi||Chairman|
|Dr. T Rajamannar||Non Executive Director|
|Dr. Robert J Spiegel||Non Executive Director|
|Mr. Sudhir V Valia||Non Executive Director|
|Ms. Bhavna Doshi||Independent Director|
|Dr. Ferzaan Engineer||Independent Director|
What is Share Price of ?
share price is ₹ As on 27 November, 2022 | 15:02